The index 'Treatment Duration Control' for enabling randomized controlled trials with variation in duration of treatment of chronic pain patients

Hilbert W van der Glas; Robert J van Grootel

doi:10.1186/1471-2288-13-123

The index 'Treatment Duration Control' for enabling randomized controlled trials with variation in duration of treatment of chronic pain patients

Hilbert W van der Glas, Robert J van Grootel

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Treatment duration varies with the type of therapy and a patient's recovery speed. Including such a variation in randomized controlled trials (RCTs) enables comparison of the actual therapeutic potential of different therapies in clinical care. An index, Treatment Duration Control (TDC) of outcome scores was developed to help decide when to end treatment and also to determine treatment outcome by a blinded assessor. In contrast to traditional Routine Outcome Monitoring which considers raw score changes, TDC uses relative change.

Original language	English
Pages (from-to)	123
Journal	BMC Medical Research Methodology
Volume	13
DOIs	https://doi.org/10.1186/1471-2288-13-123
Publication status	Published - 2013

Keywords

Arthralgia
Chronic Pain
Clinical Protocols
Humans
Long-Term Care
Pain Measurement
Quality of Life
Randomized Controlled Trials as Topic
Temporomandibular Joint Disorders
Treatment Outcome

Access to Document

10.1186/1471-2288-13-123

Cite this

@article{830da2c6bb7a43e9bd1c0e1f1bab8ace,

title = "The index 'Treatment Duration Control' for enabling randomized controlled trials with variation in duration of treatment of chronic pain patients",

abstract = "Treatment duration varies with the type of therapy and a patient's recovery speed. Including such a variation in randomized controlled trials (RCTs) enables comparison of the actual therapeutic potential of different therapies in clinical care. An index, Treatment Duration Control (TDC) of outcome scores was developed to help decide when to end treatment and also to determine treatment outcome by a blinded assessor. In contrast to traditional Routine Outcome Monitoring which considers raw score changes, TDC uses relative change.",

keywords = "Arthralgia, Chronic Pain, Clinical Protocols, Humans, Long-Term Care, Pain Measurement, Quality of Life, Randomized Controlled Trials as Topic, Temporomandibular Joint Disorders, Treatment Outcome",

author = "{van der Glas}, {Hilbert W} and {van Grootel}, {Robert J}",

year = "2013",

doi = "10.1186/1471-2288-13-123",

language = "English",

volume = "13",

pages = "123",

journal = "BMC Medical Research Methodology",

issn = "1471-2288",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - The index 'Treatment Duration Control' for enabling randomized controlled trials with variation in duration of treatment of chronic pain patients

AU - van der Glas, Hilbert W

AU - van Grootel, Robert J

PY - 2013

Y1 - 2013

N2 - Treatment duration varies with the type of therapy and a patient's recovery speed. Including such a variation in randomized controlled trials (RCTs) enables comparison of the actual therapeutic potential of different therapies in clinical care. An index, Treatment Duration Control (TDC) of outcome scores was developed to help decide when to end treatment and also to determine treatment outcome by a blinded assessor. In contrast to traditional Routine Outcome Monitoring which considers raw score changes, TDC uses relative change.

AB - Treatment duration varies with the type of therapy and a patient's recovery speed. Including such a variation in randomized controlled trials (RCTs) enables comparison of the actual therapeutic potential of different therapies in clinical care. An index, Treatment Duration Control (TDC) of outcome scores was developed to help decide when to end treatment and also to determine treatment outcome by a blinded assessor. In contrast to traditional Routine Outcome Monitoring which considers raw score changes, TDC uses relative change.

KW - Arthralgia

KW - Chronic Pain

KW - Clinical Protocols

KW - Humans

KW - Long-Term Care

KW - Pain Measurement

KW - Quality of Life

KW - Randomized Controlled Trials as Topic

KW - Temporomandibular Joint Disorders

KW - Treatment Outcome

U2 - 10.1186/1471-2288-13-123

DO - 10.1186/1471-2288-13-123

M3 - Article

C2 - 24112821

SN - 1471-2288

VL - 13

SP - 123

JO - BMC Medical Research Methodology

JF - BMC Medical Research Methodology

ER -

The index 'Treatment Duration Control' for enabling randomized controlled trials with variation in duration of treatment of chronic pain patients

Abstract

Keywords

Access to Document

Fingerprint

Cite this